Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
10
NCT03255343
Treatment of Non-responding to Conventional Therapy Inoperable Liver Cancers by in Situ Introduction of ImDendrim
Phase: N/A
Role: Lead Sponsor
Start: Mar 13, 2017
Completion: Dec 31, 2017